N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.

To access publisher's full text version of this article click on the hyperlink at the bottom of the page This study describes the structure-activity relationship for carefully characterized N-alkyl-N-quaternary chitosan derivatives as permeation enhancers for drugs that are mainly absorbed thro...

Full description

Bibliographic Details
Published in:European Journal of Pharmaceutics and Biopharmaceutics
Main Authors: Benediktsdóttir, Berglind Eva, Gudjónsson, Thórarinn, Baldursson, Ólafur, Másson, Már
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier Science BV 2014
Subjects:
Online Access:http://hdl.handle.net/2336/332604
https://doi.org/10.1016/j.ejpb.2013.04.002
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/332604
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/332604 2023-05-15T16:44:05+02:00 N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro. Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland. 2Biomedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland. 3Department of Pulmonary Medicine, Landspitali - The National University Hospital of Iceland, Reykjavík, Iceland. 4Faculty of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland Benediktsdóttir, Berglind Eva Gudjónsson, Thórarinn Baldursson, Ólafur Másson, Már 2014 http://hdl.handle.net/2336/332604 https://doi.org/10.1016/j.ejpb.2013.04.002 en eng Elsevier Science BV http://dx.doi.org/10.1016/j.ejpb.2013.04.002 Eur J Pharm Biopharm. 2014, 86 (1):55-63 1873-3441 23608635 doi:10.1016/j.ejpb.2013.04.002 http://hdl.handle.net/2336/332604 European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V Archived with thanks to European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V National Consortium - Landsaðgangur Lyfjagjöf Dose-Response Relationship Drug Chitosan/analogs & derivatives* Tight Junctions/metabolism Molecular Weight Permeability Alkylation Bronchi/cytology Bronchi/metabolism* Cell Line Cell Survival/drug effects Chitosan/chemistry Chitosan/pharmacokinetics Drug Carriers*/chemistry Drug Carriers*/pharmacokinetics Epithelial Cells/metabolism* Epithelial Cells/ultrastructure Humans Quaternary Ammonium Compounds*/chemistry Quaternary Ammonium Compounds*/pharmacokinetics Structure-Activity Relationship Tight Junctions/drug effects Article 2014 ftlandspitaliuni https://doi.org/10.1016/j.ejpb.2013.04.002 2022-05-29T08:22:00Z To access publisher's full text version of this article click on the hyperlink at the bottom of the page This study describes the structure-activity relationship for carefully characterized N-alkyl-N-quaternary chitosan derivatives as permeation enhancers for drugs that are mainly absorbed through the paracellular pathway, such as macromolecular drugs and hydrophilic drugs, in a well defined bronchial epithelial cell line. The O-methyl free derivatives used in the study were fully trimethylated (100%) N,N,N-trimethyl chitosan (TMC) and N-propyl-(QuatPropyl), N-butyl-(QuatButyl) and N-hexyl (QuatHexyl)-N,N-dimethyl chitosan, with 85-91% degree of quaternization. The fully trimethylated TMC, from 0.25mg/ml, decreased transepithelial electrical resistance (TER) in a reversible manner and enhanced the permeation of the macromolecule FITC-dextran 4kDa (FD4) 2-5 fold. TMC did not cause any alterations in the tight junction (TJ) protein claudin-4 or in F-actin architecture. QuatHexyl was the most effective polymer to produce enhanced permeation and decreased TER from 0.016mg/ml. Nevertheless, this enhanced permeation was accompanied by reduced viability and dissociation of F-actin and claudin-4 proteins. The structure-activity relationship suggests that more lipophilic derivatives show more permeation enhancement, TJ disassembly, and less viability in the order of hexyl≈butyl>propyl>methyl and demonstrates that the permeation effect is not only mediated by permanent positive charge but also by the extent of N-alkylation. These results are relevant to elucidate the structural factors contributing to the permeation enhancement of chitosan derivatives and for potential use in pulmonary applications. Eimskip Fund of University of Iceland Landspitali University Hospital Science Article in Journal/Newspaper Iceland Reykjavík Reykjavík Hirsla - Landspítali University Hospital research archive Reykjavík European Journal of Pharmaceutics and Biopharmaceutics 86 1 55 63
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language English
topic Lyfjagjöf
Dose-Response Relationship
Drug
Chitosan/analogs & derivatives*
Tight Junctions/metabolism
Molecular Weight
Permeability
Alkylation
Bronchi/cytology
Bronchi/metabolism*
Cell Line
Cell Survival/drug effects
Chitosan/chemistry
Chitosan/pharmacokinetics
Drug Carriers*/chemistry
Drug Carriers*/pharmacokinetics
Epithelial Cells/metabolism*
Epithelial Cells/ultrastructure
Humans
Quaternary Ammonium Compounds*/chemistry
Quaternary Ammonium Compounds*/pharmacokinetics
Structure-Activity Relationship
Tight Junctions/drug effects
spellingShingle Lyfjagjöf
Dose-Response Relationship
Drug
Chitosan/analogs & derivatives*
Tight Junctions/metabolism
Molecular Weight
Permeability
Alkylation
Bronchi/cytology
Bronchi/metabolism*
Cell Line
Cell Survival/drug effects
Chitosan/chemistry
Chitosan/pharmacokinetics
Drug Carriers*/chemistry
Drug Carriers*/pharmacokinetics
Epithelial Cells/metabolism*
Epithelial Cells/ultrastructure
Humans
Quaternary Ammonium Compounds*/chemistry
Quaternary Ammonium Compounds*/pharmacokinetics
Structure-Activity Relationship
Tight Junctions/drug effects
Benediktsdóttir, Berglind Eva
Gudjónsson, Thórarinn
Baldursson, Ólafur
Másson, Már
N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
topic_facet Lyfjagjöf
Dose-Response Relationship
Drug
Chitosan/analogs & derivatives*
Tight Junctions/metabolism
Molecular Weight
Permeability
Alkylation
Bronchi/cytology
Bronchi/metabolism*
Cell Line
Cell Survival/drug effects
Chitosan/chemistry
Chitosan/pharmacokinetics
Drug Carriers*/chemistry
Drug Carriers*/pharmacokinetics
Epithelial Cells/metabolism*
Epithelial Cells/ultrastructure
Humans
Quaternary Ammonium Compounds*/chemistry
Quaternary Ammonium Compounds*/pharmacokinetics
Structure-Activity Relationship
Tight Junctions/drug effects
description To access publisher's full text version of this article click on the hyperlink at the bottom of the page This study describes the structure-activity relationship for carefully characterized N-alkyl-N-quaternary chitosan derivatives as permeation enhancers for drugs that are mainly absorbed through the paracellular pathway, such as macromolecular drugs and hydrophilic drugs, in a well defined bronchial epithelial cell line. The O-methyl free derivatives used in the study were fully trimethylated (100%) N,N,N-trimethyl chitosan (TMC) and N-propyl-(QuatPropyl), N-butyl-(QuatButyl) and N-hexyl (QuatHexyl)-N,N-dimethyl chitosan, with 85-91% degree of quaternization. The fully trimethylated TMC, from 0.25mg/ml, decreased transepithelial electrical resistance (TER) in a reversible manner and enhanced the permeation of the macromolecule FITC-dextran 4kDa (FD4) 2-5 fold. TMC did not cause any alterations in the tight junction (TJ) protein claudin-4 or in F-actin architecture. QuatHexyl was the most effective polymer to produce enhanced permeation and decreased TER from 0.016mg/ml. Nevertheless, this enhanced permeation was accompanied by reduced viability and dissociation of F-actin and claudin-4 proteins. The structure-activity relationship suggests that more lipophilic derivatives show more permeation enhancement, TJ disassembly, and less viability in the order of hexyl≈butyl>propyl>methyl and demonstrates that the permeation effect is not only mediated by permanent positive charge but also by the extent of N-alkylation. These results are relevant to elucidate the structural factors contributing to the permeation enhancement of chitosan derivatives and for potential use in pulmonary applications. Eimskip Fund of University of Iceland Landspitali University Hospital Science
format Article in Journal/Newspaper
author Benediktsdóttir, Berglind Eva
Gudjónsson, Thórarinn
Baldursson, Ólafur
Másson, Már
author_facet Benediktsdóttir, Berglind Eva
Gudjónsson, Thórarinn
Baldursson, Ólafur
Másson, Már
author_sort Benediktsdóttir, Berglind Eva
title N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
title_short N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
title_full N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
title_fullStr N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
title_full_unstemmed N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
title_sort n-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro.
publisher Elsevier Science BV
publishDate 2014
url http://hdl.handle.net/2336/332604
https://doi.org/10.1016/j.ejpb.2013.04.002
geographic Reykjavík
geographic_facet Reykjavík
genre Iceland
Reykjavík
Reykjavík
genre_facet Iceland
Reykjavík
Reykjavík
op_relation http://dx.doi.org/10.1016/j.ejpb.2013.04.002
Eur J Pharm Biopharm. 2014, 86 (1):55-63
1873-3441
23608635
doi:10.1016/j.ejpb.2013.04.002
http://hdl.handle.net/2336/332604
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V
op_rights Archived with thanks to European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V
National Consortium - Landsaðgangur
op_doi https://doi.org/10.1016/j.ejpb.2013.04.002
container_title European Journal of Pharmaceutics and Biopharmaceutics
container_volume 86
container_issue 1
container_start_page 55
op_container_end_page 63
_version_ 1766034402121351168